Last reviewed · How we verify

NCT04978415: subtenon's

Peribulbar Block Versus Subtenon's Injection in Redo Vitreoretinal Surgery

Status unknown NA Last updated 13 September 2022
What this trial tests

NA trial testing peribulbar block versus subtenon's block in Analgesia in 60 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
30 November 2022
30 November 2022

Quick facts

Lead sponsorAbeer Samir Salem
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposescreening
Enrollment60
Start date1 October 2021
Primary completion30 November 2022
Estimated completion30 November 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Abeer Samir Salem

Who can join

Adults 18 to 80, any sex, with Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy and efficiency of peribulbar block versus sub-Tenon's capsule injection of local anesthetic in redo vitreoretinal surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04978415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing